Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02350634 · ClinicalTrials.gov registry record · Phase 1
18F-AV-1451 High Resolution Autopsy Study
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02350634 is a Phase 1 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 3 participants.
The verdict
NCT02350634, a Phase 1 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.
Interventions
- DRUG Flortaucipir F18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-11-26 |
| Est. Completion | 2017-06-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02350634
The ClinicalTrials.gov registry entry for NCT02350634 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flortaucipir F18 is the first listed.
NCT02350634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02350634 about?
NCT02350634 is a clinical study titled "18F-AV-1451 High Resolution Autopsy Study". The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.
What is the current status of trial NCT02350634?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2016-11-26. Estimated completion is 2017-06-16.
What interventions are being tested in trial NCT02350634?
The interventions under investigation include: Flortaucipir F18 (DRUG).
Who is sponsoring clinical trial NCT02350634?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.